CD34 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD34 monoclonal antibodies for various research applications. CD34 monoclonal antibodies excel in techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD34 is a cell surface glycoprotein that serves as a marker for hematopoietic stem and progenitor cells, playing a crucial role in cell adhesion and migration. CD34 expression is vital for the identification and isolation of stem cells in both research and clinical settings, making CD34 monoclonal antibodies essential tools in the study of hematopoiesis and regenerative medicine. Understanding CD34 function can provide insights into various diseases, including leukemias and other hematological disorders. CD34 monoclonal antibodies enable researchers to explore cellular mechanisms and pathways involved in stem cell development and differentiation. CD34 monoclonal antibodies support investigations into potential therapeutic approaches for blood disorders and regenerative medicine applications. Santa Cruz Biotechnology CD34 monoclonal antibodies empower researchers worldwide to advance scientific understanding of stem cell biology and its impact on human health.